Acadia Pharmaceuticals Inc
- Stock
- Ticker ACAD
- ISIN US0042251084
- Nasdaq
Performance, volatility and drawdowns of Acadia Pharmaceuticals Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $5,976. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −77.2% in 06/2022, measured from the peak in 07/2020. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 260 | 244 | 265 | 279 | 284 | 268 | 308 | 342 |
| Gross profit | 238 | 224 | 244 | 257 | 258 | 243 | 280 | 307 |
| Operating income | 154 | 19 | 32 | 36 | 17 | -4.6 | 38 | 72 |
| EBITDA | 154 | 20 | 33 | 36 | 18 | -4.3 | 38 | 72 |
| Net income | 144 | 19 | 27 | 72 | 274 | 3.6 | 32 | 54 |
| Earnings per share | 0.86 | 0.11 | 0.16 | 0.42 | 1.61 | 0.02 | 0.18 | 0.31 |
| Balance sheet | ||||||||
| Total assets | 1,188 | 1,132 | 1,226 | 1,331 | 1,564 | 1,605 | 1,743 | 1,794 |
| Liabilities | 455 | 367 | 403 | 413 | 337 | 357 | 436 | 407 |
| Equity | 733 | 765 | 822 | 917 | 1,227 | 1,248 | 1,307 | 1,387 |
| Cash | 320 | 218 | 254 | 258 | 178 | 282 | 385 | 322 |
| Cash flow | ||||||||
| Operating cash flow | 40 | 20 | 64 | 74 | -49 | 34 | 101 | 12 |
| Capital expenditure | -0.5 | 0.0 | -0.3 | -0.4 | -4.0 | -5.2 | -5.1 | -1.2 |
| Free cash flow | 40 | 20 | 64 | 74 | -53 | 29 | 96 | 10 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2019 at +164.6%, weakest 2021 at −56.3%. 5 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | $0.31 |
| 5 Aug 2026 | $0.18 |
| 7 May 2026 | $0.02 |
| 26 Feb 2026 | $1.61 |
| 6 Nov 2025 | $0.42 |
| 7 Aug 2025 | $0.16 |
| 8 May 2025 | $0.11 |
| 27 Feb 2025 | $0.86 |
| 7 Nov 2024 | $0.20 |
| 7 Aug 2024 | $0.20 |
| 9 May 2024 | $0.10 |
| 28 Feb 2024 | $0.28 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €2.7bn
- Market cap in trading currency
- $2.96bn
- Enterprise value
- $1.98bn
- P/E
- 8.1
- P/S
- 2.46
- P/B
- 2.13
- EV/Sales
- 1.65
- EV/EBITDA
- 16.0
- Earnings yield
- 12.4%
- FCF yield
- 2.8%
Results (last four quarters)
- Revenue
- $1.20bn
- Gross profit
- $1.09bn
- EBITDA
- $124m
- Net income
- $362m
- Earnings per share
- $2.12
- Revenue per share
- $6.96
- Revenue growth
- +22.8%
- Earnings growth
- −25.4%
Profitability
- Gross margin
- 90.5%
- Operating margin
- 10.2%
- Net margin
- 30.1%
- Return on equity
- 31.4%
- Return on assets
- 20.2%
Balance sheet and cash flow
- Cash
- $976m
- Cash per share
- $5.65
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 3.82
- Book value per share
- $8.03
- Operating cash flow
- $97.5m
- Free cash flow
- $82.0m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 173m
- Volume
- 1.90m
- Avg. volume 3 months
- 2.19m
- Relative volume
- 0.9
Price and technicals
- Price
- $17.11
- 1 day
- −2.7%
- 52-week high
- $30.57
- 52-week low
- $16.50
- Distance to 52-week high
- −44.0%
- Distance to 52-week low
- +3.7%
- Distance to 50-day line
- −17.7%
- Distance to 200-day line
- −26.1%
- RSI (14)
- 34
- Volatility 1M
- 100.3%
Performance
- 1 week
- −8.7%
- 1 month
- −15.8%
- 3 months
- −42.3%
- 6 months
- −18.9%
- YTD
- −35.9%
- 1 year
- −25.9%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has ACAD performed since 11/2016?
$10,000 grew to $5,976 by 20 Nov 2026, which is −5.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is ACAD?
Volatility was 52.2% per year, measured on monthly returns. The largest decline from a peak was −77.2%, with the low in 06/2022.
How does ACAD compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ACAD returned −5.0% at 52.2%. The correlation of monthly returns was 0.25; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.